Related Experiment Video

Updated: Sep 26, 2026

miRNA Expression Analyses in Prostate Cancer Clinical Tissues
11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

Concordant down-regulation of proto-oncogene PML and major histocompatibility antigen HLA class I expression in

Huiming Zhang1, Jonathan Melamed, Ping Wei

  • 1Department of Pathology, Division of Cancer Immunology, The Ohio State University Medical Center, Columbus, OH 43210, USA.

Cancer Immunity
|May 16, 2003
PubMed

Insights

In high-grade prostate cancer, the promyelocytic leukemia (PML) proto-oncogene malfunction is linked to reduced HLA class I expression. This down-regulation hinders tumor cell recognition by T lymphocytes, impacting immune evasion.

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • Cytolytic T lymphocyte recognition of tumor cells relies on MHC class I expression.
  • Malignant cancers, including prostate cancer, often down-regulate MHC class I to evade immune detection.
  • The molecular mechanisms behind MHC class I down-regulation in most human cancers remain unclear.

Purpose of the Study:

  • To investigate the expression of the promyelocytic leukemia (PML) proto-oncogene and MHC class I in high-grade prostate cancer.
  • To determine if PML malfunction contributes to MHC class I down-regulation in prostate adenocarcinoma.

Main Methods:

  • Analysis of HLA class I and PML protein expression in 37 high-grade prostate adenocarcinoma cases.
  • Correlation of HLA class I and PML expression levels with Gleason grade.
  • Examination of histological patterns for concordant HLA and PML down-regulation.

Main Results:

  • 81% of prostate adenocarcinoma cases (Gleason grade 7-8) showed >50% down-regulation of HLA class I.
  • 73.3% of these cases had undetectable PML protein, and 13.3% had partial PML down-regulation.
  • All cases with high HLA class I expression exhibited high PML levels, indicating a concordant relationship.

Conclusions:

  • Malfunction of the PML proto-oncogene is a significant factor in the down-regulation of cell surface HLA class I in high-grade prostate cancer.
  • Reduced HLA class I expression impairs direct recognition of cancer cells by cytolytic T lymphocytes.
  • PML may be a key regulator of antigen presentation genes in prostate cancer.

More Related Videos

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR (qPCR)08:30

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR (qPCR)

Published on: May 16, 2012

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...